Stockscreener 앱 받기
4.14
0.49%
0.02
시간 외 거래:
4.12
-0.02
-0.48%
Cytomx Therapeutics Inc 주식(CTMX)의 최신 뉴스
Is CytomX Therapeutics Inc a good long term investmentVolume Analysis Techniques & Free Trading Signals to Sharpen Your Edge - earlytimes.in
What drives CytomX Therapeutics Inc 6C1 stock priceEmerging Market Stocks & High Return Stock Picks - earlytimes.in
What analysts say about CytomX Therapeutics Inc 6C1 stockEquity Performance Review & Collaborate and Win Together - earlytimes.in
CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year HighHere's Why - MarketBeat
What drives CytomX Therapeutics Inc stock priceWeekly Market Snapshot & Investor Community Interactions - earlytimes.in
Chart Watch: Is CytomX Therapeutics Inc stock a safe investment in uncertain markets2025 Bull vs Bear & Verified Short-Term Trading Plans - moha.gov.vn
Will CytomX Therapeutics Inc. stock recover faster than peersChart Pattern Recognition & Exceptional Return Stocks - bollywoodhelpline.com
237,081 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Precision Wealth Strategies LLC - MarketBeat
Inspire Investing LLC Acquires Shares of 522,482 CytomX Therapeutics, Inc. $CTMX - MarketBeat
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
CytomX Therapeutics (STU:6C1) EV-to-OCF : -7.46 (As of Dec. 26, 2025) - GuruFocus
CytomX Therapeutics (NASDAQ:CTMX) Trading Up 5.4%Here's Why - MarketBeat
CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) (NASDAQ:CTMX) - Seeking Alpha
CTMX (CytomX Therapeutics) EV-to-OCF : -7.47 (As of Dec. 22, 2025) - GuruFocus
CytomX Therapeutics, Inc.(NasdaqGS:CTMX) added to S&P Biotechnology Select Industry Index - marketscreener.com
Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress - Insider Monkey
Can CytomX Therapeutics Inc. stock sustain free cash flow growthJuly 2025 News Drivers & Weekly High Return Opportunities - ulpravda.ru
Market Outlook: Why CytomX Therapeutics Inc stock could outperform in 2025Buy Signal & Free High Accuracy Swing Entry Alerts - moha.gov.vn
Sell Signal: Will CytomX Therapeutics Inc stock recover faster than peersJuly 2025 Summary & High Return Trade Guides - moha.gov.vn
Is CytomX Therapeutics Inc. stock a top pick in earnings seasonPortfolio Update Report & Expert Verified Stock Movement Alerts - Улправда
How CytomX Therapeutics Inc. stock trades during market volatilityJuly 2025 Update & Fast Gain Swing Trade Alerts - Улправда
Is CytomX Therapeutics Inc. (6C1) stock undervalued by metricsJuly 2025 Sentiment & Community Trade Idea Sharing Platform - Улправда
Is CytomX Therapeutics Inc. stock gaining market share2025 Geopolitical Influence & Technical Pattern Recognition Alerts - Улправда
Is CytomX Therapeutics Inc. stock a safe investment in uncertain marketsJuly 2025 PreEarnings & AI Driven Price Forecasts - DonanımHaber
CytomX Therapeutics' (NASDAQ:CTMX) earnings growth rate lags the 256% return delivered to shareholders - simplywall.st
Pullback Watch: What market sentiment indicators show for CytomX Therapeutics Inc. (6C1) stockMarket Performance Recap & Long-Term Safe Investment Plans - Улправда
Aug Opening: Is CytomX Therapeutics Inc. stock gaining market shareJuly 2025 PostEarnings & AI Enhanced Trading Alerts - Улправда
Will CytomX Therapeutics Inc. stock split attract more investorsBuy Signal & Expert-Curated Trade Recommendations - Улправда
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 3.5%What's Next? - MarketBeat
Market Overview: Will CytomX Therapeutics Inc. stock split attract more investorsTake Profit & Fast Momentum Stock Entry Tips - Улправда
CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling - Seeking Alpha
CytomX Therapeutics2025 Funding Rounds & List of Investors - Tracxn
5,769,230 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Vivo Capital LLC - MarketBeat
Can CytomX Therapeutics Stock Recover If Markets Fall? - Trefis
What analysts say about CytomX Therapeutics Inc stockVolume Weighted Average Price & Explosive Profit Potential - earlytimes.in
With CytomX Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
What Analysts Think Is Changing the CytomX Therapeutics Story After Recent Cancer Developments - Yahoo Finance
CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data By Investing.com - Investing.com South Africa
CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data - Investing.com UK
Is CytomX Therapeutics Inc. stock a contrarian buyJuly 2025 PostEarnings & Technical Confirmation Alerts - Newser
Will CytomX Therapeutics Inc. stock beat EPS estimatesMarket Performance Report & Reliable Breakout Forecasts - Newser
Is CytomX Therapeutics Inc. (6C1) stock suitable for passive index funds2025 Earnings Surprises & Safe Entry Momentum Tips - Newser
Why CytomX Therapeutics Inc. (6C1) stock is listed among top recommendationsTrade Entry Report & High Accuracy Trade Alerts - Newser
Is CytomX Therapeutics Inc. (6C1) stock attractive post correctionProduct Launch & Real-Time Stock Movement Alerts - Newser
Published on: 2025-12-04 14:11:00 - Newser
Will CytomX Therapeutics Inc. (6C1) stock sustain dividend payoutsJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
Would You Still Hold CytomX Therapeutics Stock If It Fell Another 30%? - Trefis
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 6.5%What's Next? - MarketBeat
Is CytomX Therapeutics Inc. (6C1) stock ideal for retirement investorsJuly 2025 Patterns & Fast Gain Stock Trading Tips - Newser
What insider purchases suggest about CytomX Therapeutics Inc. (6C1) stockFed Meeting & Fast Gain Stock Trading Tips - Newser
Is CytomX Therapeutics Inc. (6C1) stock a buy on weaknessQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
Will CytomX Therapeutics Inc. (6C1) stock outperform Dow JonesSell Signal & High Return Stock Watch Alerts - Newser
How CytomX Therapeutics Inc. (6C1) stock reacts to weak economy2025 Price Targets & Entry Point Confirmation Alerts - Newser
2.52%
0.07%
자본화:
|
볼륨(24시간):